Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Columbia University.
Recruitment status was  Recruiting
Celgene Corporation
Information provided by (Responsible Party):
Columbia University Identifier:
First received: December 20, 2007
Last updated: November 2, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)